Use of the polymerase chain reaction for the diagnosis of American tegumentary leishmaniasis

Barçante, Thales Augusto; Souza, Marcos Vilela de; Fernandes, Allana Cristina Baltazar; Barçante, Joziana Muniz de Paiva

doi:10.1590/abd1806-4841.20197929

Cited by 4 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The second sample was used for imprint with staining, which also revealed no amastigote forms of the parasite. Subsequently, the same material was preserved in sterile saline solution, macerated with 300μg of extraction buffer, and frozen in a properly identified flask for PCR as described by Barçante et al, 2019. After analyzing the electrophoretic pattern of the sample with the positive control, the presence of Leishmania spp.…”

Section: Introductionmentioning

confidence: 99%

Intralesional administration of meglumine antimoniate (MA) as an alternative treatment for cutaneous leishmaniasis: a case report

Souza¹,

Cherem²,

Júnior³

et al. 2023

Braz. J. Hea. Rev.

View full text Add to dashboard Cite

Cutaneous leishmaniasis (CL) is not a life-threatening condition, the treatment of which can cause serious adverse effects and sometimes lead to death. In this study, we report a case of success in the treatment of LC of a 2.5 cm lesion located in the neck region of a 22-year-old man treated with intralesional meglumine antiomoniate (IL-MA) without adverse effects and without recurrence or complications after 18 months of follow-up. The results suggest that the treatment of CL lesions with IL-MA is simple, efficient and safe.

show abstract

Section: Introductionmentioning

confidence: 99%